What is the IMPACT-2 Study? A clinical trial exploring the effect of an investigational, psychoactive oral medication for PTSD symptoms.
Who can participate? People who have experienced a traumatic event and are now suffering symptoms of post-traumatic stress disorder (PTSD).
Where? The study is being conducted at select locations in the US and UK. Click here to view a list of current study locations.
When? Now - the study is actively enrolling new participants.
If you qualify, what can you expect from the IMPACT-2 Study?
If you are dealing with stress, anxiety, or insomnia due to a traumatic event, you may qualify for the IMPACT-2 Study. See if you qualify and be connected to a participating site nearest to you by filling out a brief questionnaire.
United States
Many people will experience a life-threatening traumatic event in their lifetime, including but not limited to:
Events such as these can trigger a range of symptoms, including.
While these symptoms often go away in a few weeks, for some they never go away and linger for months or even years – a condition known as post-traumatic stress disorder (PTSD).